Testing effectiveness (Phase 2)Ended earlyNCT02700048
What this trial is testing
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
Who this might be right for
Hypoglycemia UnawarenessType 1 Diabetes
University of Minnesota 11
Showing 20 of 0 results